TINA JONES: Open Payments
NPI 1700341831 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,973 in 78 payments from 16 companies in 2025. Trend: 2023 $1,110 · 2024 $2,561 · 2025 $2,973
Food & beverage: $2,888Education: $85
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 12 | $846 |
| Janssen Biotech, Inc. | 19 | $553 |
| ABBVIE INC. | 13 | $327 |
| Ipsen Biopharmaceuticals, Inc | 5 | $322 |
| GENZYME CORPORATION | 5 | $222 |
| QOL Medical, LLC | 5 | $141 |
| Aimmune Therapeutics, Inc. | 2 | $113 |
| Gilead Sciences, Inc. | 2 | $96 |
| Ardelyx, Inc. | 3 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $76 |
Products named: REZDIFFRA, TREMFYA, IQIRVO, DUPIXENT, SKYRIZI, Sucraid, RINVOQ, VOWST.
Industry payments across AZ — which companies pay providers there.
